Responding to COVID-19: A Science-Based Approach

Brought to you by the American Public Health Association and the National Academy of Medicine, this webinar series will explore the state of the science surrounding the current outbreak of COVID-19 in the United States and globally, with a focus on the emerging evidence on how to best mitigate its impact. Hear from trusted experts in such fields as public health, infectious disease, risk communication, and crisis standards of care.

Webinar #2: The Science of Social Distancing, Part 2
Wednesday, April 1, 5-6:30 p.m.
REGISTER NOW

The second COVID-19 Conversations webinar will: discuss benefit-risk analysis of social/physical distancing strategies, including for vulnerable populations; examine strategies for mitigating mental health impacts; and explore what science is available to guide eventual relaxation of measures.

The webinar's panel of expert speakers:

Sharon Inouye Anne Schuchat Sandro Galea Jason Karlawish Jennifer Nuzzo

  • Sharon Inouye, MD, MPH (Moderator) — Professor of Medicine, Harvard University Medical School
  • Anne Schuchat, MD — Principal Deputy Director, Centers for Disease Control and Prevention
  • Sandro Galea, MD, MPH, DrPH — Dean and Robert A. Knox Professor, Boston University School of Public Health
  • Jason Karlawish, MD — Professor of Medicine, University of Pennsylvania Perelman School of Medicine
  • Jennifer Nuzzo, DrPH, SM — Senior Scholar, Johns Hopkins Center for Health Security

Speaker presentations will be followed by a Q&A session with the webinar audience.

Webinar #1: The Science of Social Distancing, Part 1

In our first COVID-19 Conversations webinar, our lineup of public health, medical and emergency experts shared the science on social distancing as well as strategies to support it. And we explored how findings from past pandemics — as well as the current one — can shape responses today. 

More about the webinar series

The webinar series will draw from and complement existing advisory activities underway at APHA and the National Academies, including the Standing Committee on Emerging Infectious Diseases and 21st Century Health Threats, which was convened for the purpose of advising the White House and federal agencies on the U.S. response to COVID-19.

The series will rapidly and regularly provide trustworthy scientific analysis of the latest COVID-19 developments for the benefit of policymakers, public health and health care officials, and the general public. The series will explore the scientific basis for guidance issued by government, health and public health organizations, and industry, as well as answer questions that are top of mind for its audiences.

Questions? Contact us.